BI-44847
BI-44847 is a selective and orally active SGLT2 inhibitor. BI-44847 can increase UGE and decrease HbA1c levels. BI-44847 shows improvement in fasting and fed glucose levels. BI-44847 can be studied in research on type 2 diabetes mellitus (T2DM) [1].
Product Specifications
CAS Number
[421592-30-5]
UNSPSC
12352005
Target
SGLT
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@H]1OC2=NN(C(C)C)C(C)=C2CC3=CC=C(OC)C=C3F
Molecular Formula
C21H29FN2O7
Molecular Weight
440.46
References & Citations
[1]Malla, P., et al. (2014) . Ramping glucosuria for management of type 2 diabetes mellitus: an emerging cynosure. Medicinal research reviews, 34 (6), 1146-1167.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-117075/
Scientific Category
Reference compound1
Clinical Information
Phase 1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1132022-01 0.02 mg (E-Coli)
Recombinant Desulfovibrio vulgaris tRNA pseudouridine synthase B (truB)
Ask
View Details MBS1132022-02 0.02 mg (Yeast)
Recombinant Desulfovibrio vulgaris tRNA pseudouridine synthase B (truB)
Ask
View Details MBS1132022-03 0.1 mg (E-Coli)
Recombinant Desulfovibrio vulgaris tRNA pseudouridine synthase B (truB)
Ask
View Details 
MBS1132022-04 0.1 mg (Yeast)
Recombinant Desulfovibrio vulgaris tRNA pseudouridine synthase B (truB)
Ask
View Details MBS1132022-05 0.02 mg (Baculovirus)
Recombinant Desulfovibrio vulgaris tRNA pseudouridine synthase B (truB)
Ask
View Details